Adenovirus as vector for HIV: efficacy and safety issues.

Natuk, R J; Wade, M S; Chengalvala, M; Murthy, K K; Chanda, P K; Murthy, S C; Bhat, B M; Bhat, R; Dheer, S K; Mizutani, S

Natuk, R J; Wade, M S; Chengalvala, M; Murthy, K K; Chanda, P K; Murthy, S C; Bhat, B M; Bhat, R; Dheer, S K; Mizutani, S.

Affiliation

Natuk RJ; Wyeth-Ayerst Research, Biotechnology and Microbiology Division, Philadelphia, PA, USA.

Dev Biol Stand ; 84: 153-6, 1995.

Article in En | MEDLINE | ID: mdl-7796948

Subject(s)

AIDS Vaccines/isolation & purification; Adenoviruses, Human/immunology; Genetic Vectors; HIV-1/immunology; Vaccines, Synthetic/isolation & purification; AIDS Vaccines/adverse effects; AIDS Vaccines/standards; Adenoviruses, Human/genetics; Administration, Oral; Animals; Female; HIV Antibodies/biosynthesis; HIV-1/genetics; HIV-1/physiology; Humans; Immunization Schedule; Pan troglodytes; Safety; Vaccines, Synthetic/adverse effects; Vaccines, Synthetic/standards; Virus Replication

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Vaccines, Synthetic / Adenoviruses, Human / HIV-1 / AIDS Vaccines / Genetic Vectors Limits: Animals / Female / Humans Language: En Journal: Dev Biol Stand Year: 1995 Document type: Article

Search on Google

XML

PubMed Links